| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000028213 |
| Receipt No. | R000032294 |
| Official scientific title of the study | Effect of smoking habit on lung function tests |
| Date of disclosure of the study information | 2017/07/13 |
| Last modified on | 2017/12/13 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Effect of smoking habit on lung function tests | |
| Title of the study (Brief title) | Effect of smoking habit on lung function tests | |
| Region |
|
|
| Condition | |||
| Condition | NA | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Investigate the effect of smoking habit on lung function tests in healthy Japanese subjects. |
| Basic objectives2 | Others |
| Basic objectives -Others | spirometry (FVC, FEV1.0. FEV1/FVC) |
| Trial characteristics_1 | Others |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Calculate basic statistics of smoker and non-smoker separately.
Calculate basic statistics of lung function tests with/without bronchodilator (Beta 2 blocker) when the data is available. Conduct inter-group comparison of smoker / non-smoker or with / without bronchodilator. Compare acquired data with historical data. |
| Key secondary outcomes | Calculate basic statistics of sex, age, exhaled CO level, the number of cigarette smoke in smokers. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Male and Female Japanese subjects who participated clinical trial between December 2016 and May 2017, and who has following test data;
- Demography: age, sex, height, weight and BMI. - General laboratory data and vital sign: BP (systolic and diastolic), pulse rate, laboratory data (WBC, Hb, Ht), Urine drug test. - Lung function tests: FVC, FEV1.0, FEV1/FVC - Other ( only for smoker): urine cotinine test (qualitative), exhaled Co and the number of cigarette smoked. |
|||
| Key exclusion criteria | - | |||
| Target sample size | 240 | |||
| Research contact person | |
| Name of lead principal investigator | Tatsuya Yoshihara |
| Organization | SOUSEIKAI Fukuoka Mirai Hospital Clinical Research Center |
| Division name | Clinical Pharmacology Department |
| Address | 3-5-1 Kashiiteriha, Higashi-ku, Fukuoka |
| TEL | 092-662-3608 |
| tatsuya-yoshihara@lta-med.com | |
| Public contact | |
| Name of contact person | Hiroko Kumashiro |
| Organization | SOUSEIKAI Hakata Clinic |
| Division name | Planning & Coordination Dept. |
| Address | Random Square (5th-7th floors) 6-18 Tenyamachi, Hakata-ku, Fukuoka, 812-0025 |
| TEL | 092-283-7701 |
| Homepage URL | |
| hiroko-kumashiro@lta-med.com | |
| Sponsor | |
| Institute | SOUSEIKAI Fukuoka Mirai Hospital Clinical Research Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 医療法人相生会 福岡みらい病院 臨床研究センター(福岡県)
医療法人相生会 博多クリニック(福岡県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | Function of lung is evaluated by spirometry (FVC, FEV1.0. FEV1/FVC). These data of patients with respiratory illness is widely available, but data of healthy population is very limited.
We have been accumulating spirometry data in both healthy smokers and non-smokers. We also acquired lung function test data with/without bronchodilator in healthy smokers to evaluate reversibility. In this study, we will investigate the effect of smoking habit on lung function by comparing data of healthy smokers and non- smokers. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032294 |